UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): April 5, 2013
SPECTRASCIENCE, INC.
(Exact name of registrant as specified in its charter)
| Minnesota | 000-13092 | 41-1448837 |
| (State of other jurisdiction of | (Commission File Number) | (I.R.S. Employer |
| incorporation) | Identification No.) |
11568-11 Sorrento Valley Road, San Diego, CA 92121
(Address of principal executive offices) (Zip Code)
Registrant’s telephone number, including area code:(858) 847-0200
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registration under any of the following provisions (see General Instruction A.2. below):
| o | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
| Item 2.02 | Results of Operations and Financial Condition. |
On April 5, 2013, SpectraScience, Inc. (the “Company”) held a conference call to discuss recent operational and financial developments in the Company’s business. The script for the Company’s conference call is furnished as Exhibit 99.1 to this Form 8-K.
| Item 7.01 | Regulation FD Disclosure. |
The information set forth in response to Item 2.02 of this Form 8-K is incorporated by reference in response to this Item 7.01.
| Item 9.01 | Financial Statements and Exhibits. |
| (a) | Financial statements: None. |
| (b) | Pro forma financial information: None. |
| (c) | Shell company transactions: None. |
| (d) | Exhibits: |
| 99.1 | Script from business update call held April 5, 2013. |
| -2- |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Dated: April 5, 2013
| SPECTRASCIENCE, INC. | ||
| By | /s/ Jim Dorst | |
| Jim Dorst | ||
| Chief Financial Officer and Chief Operating Officer |
| -3- |
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
EXHIBIT INDEX TO FORM 8-K
| Date of Report: | Commission File No.: | |
| April 5, 2013 | 001-13092
| |
| SPECTRASCIENCE, INC. | ||
| Exhibit | ||
| No. | Description | |
| 99.1 | Script from business update call held April 5, 2013. |
| -4- |